White House press secretary Jen Psaki has COVID; FDA delays decision on Moderna vaccine for kids 12 and over: COVID updates – USA TODAY
Show Caption Hide Caption If you had COVID and were double vaccinated you may not need a booster Research suggests COVID infection plus vaccination provides the strongest protection against a wide range of variants, possibly for a long time. Just The FAQs, USA TODAY Regulatory approval of Moderna’s emergency use authorization request for its vaccine for kids 12 to 17 years of age has been delayed until at least January, the company announced Sunday. The Massachusetts-based pharmaceutical firm said in a statement that the Food and Drug Administration blamed the delay on an ongoing evaluation of recent international analyses of the risk of myocarditis – inflammation of the heart – after vaccination. Moderna is working closely with the FDA and “is grateful to the FDA for their diligence,” the statement said. An increased risk of myocarditis from the vaccines has been discovered, particularly in young men following the second dose. The U.S. Centers for Disea...